ArticleFrontiers in medicine2025
Disease burden and attributable risk factors for chronic obstructive pulmonary disease in China, Japan, and South Korea: trends for 1990 to 2021 period and predictions for 2031.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Diverging Trajectories of Lung Cancer Burden in China, Japan, and South Korea: A Comparative Risk Assessment from the Global Burden of Disease Study 1990-2021.Thoracic cancer · 2026Article
- Risk Factors and Prediction of Chronic Obstructive Pulmonary Disease After Pulmonary Tuberculosis: A Prospective Cohort Study.International journal of chronic obstructive pulmonary disease · 2026Article
- Global, Regional, and National Burden of Chronic Obstructive Pulmonary Disease-Associated Heart Failure: A Systematic Analysis of the Global Burden of Disease Study from 1990 to 2021 with Projections up to 2050.International journal of chronic obstructive pulmonary disease · 2026Article
- The Multidimensional Burden of COPD in China: A Propensity Score-Matched Comparison with Other Prevalent Non-Communicable Diseases.International journal of chronic obstructive pulmonary disease · 2026Article
- Burden of lower respiratory infections in five East Asian countries from 1990 to 2021: observation, comparison, and forecast from the global burden of disease study 2021.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a key public health concern in East Asia. China, Japan, and South Korea represent important regions in East Asia, and the three countries have various similarities in terms of culture, economic development models, and population structure. Therefore, understanding the COPD burden in these three countries is crucial for the prevention and management of COPD in East Asian. Methods: Age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), age-standardized disability-adjusted life rate (ASDR), age-period-cohort (APC) analysis, and Bayesian age-period-cohort (BAPC) analysis data of COPD in China, Japan, and South Korea were collected and determined using the GBD (Global Burden of Disease) 2021 database. Results: China had the highest COPD burden between 1990 and 2021, followed by South Korea, and Japan. The dominant risk factor related to mortality rates and DALYs was environmental/occupational risks in China, whereas behavioral risks in Japan and South Korea were more significant. BAPC predictions indicated that the ASIR, ASPR, and ASDR for COPD in China, Japan, and South Korea would exhibit a downward trend between 2021 and 2031. However, the trend of the age-standardized mortality rate (ASMR) would vary among the three countries. Conclusion: Under the influence of environmental conditions, the aging population, economic development trends, and the construction of medical security systems, China, Japan, and South Korea share commonalities as well as differences in terms of COPD burden. China's actions concerning environmental protection have been effective, although reducing smoking rates and alleviating the pollution caused by industrialization are crucial for further reducing the COPD burden in China. Owing to Japan's environmental protection policies, low smoking rates, and comprehensive social security measures, the COPD burden in Japan is relatively low compared to that in China and South Korea. Owing to the impact of environmental pollution, imperfections in the medical security system, and the influence of South Korea's handling of related issues after the economic rise of the nation, the COPD burden in South Korea has undergone significant fluctuations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.